LONDON - Aterian Plc (LSE: ATN), a London Stock Exchange-listed company specializing in the exploration and development of critical metals, has announced an increase in the allocation of shares to its ...

The program is part of a larger project that has enrolled more than 30,000 young people in HIV care and prevention studies ...

ATN-022 is an antibody-drug conjugate (ADC) designed to target CLDN18.2, a member of the Claudin family of cell adhesion molecules. Under normal conditions, Claudins are located within tight ...

Sherwin-Williams Posts Weak Results, Joins Logitech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ...

Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from its Phase I/II CLINCH study ongoing in China and Australia evaluating ATN-022 ...